Search results
How Trump could upend vaccines
Politico· 7 days agoFunding for the Radiation Exposure Compensation Act expired Friday, leaving people who have been exposed to nuclear radiation — including those who live “downwind” of the Nevada Test
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days agoThe most common side effects of the new shot included pain at the injection site, fatigue, muscle...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
The Kansas City Star· 4 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 6 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 7 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 4 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine< ...
FDA Gives Nod to RSV Vaccine for People in Their 50s | FOX 28 Spokane
FOX 28 Spokane· 7 days agoThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a...